Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

NCT01617434 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01617434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01617434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2012
Completion date
October 31, 2013
Enrollment
451 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2